Will the Next Big Brain Cancer Drug be Derived from Marijuana?
GW Pharmaceuticals is close to venturing where no other pharmaceutical company has gone before. The U.K.-based company is poised to win the first-ever U.S. approval for a cannabis-derived therapy. Early trials of the therapy suggest that this treatment could also…
Read more